|
 |
zoledronic acidThis page contains recent news articles, when available, and an overview of zoledronic acid but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.The bisphosphonate zoledronic acid (zoledronate) has been shown to reduce osteoclast activity, and its local administration is a potentially attractive ... Journal of Bone and Joint Surgery (subscription) SABCS: Novel Biologic Beats Zoledronic Acid for Bone Mets - Dec 11, 2009 There have also been concerns over osteonecrosis of the jaw, which was numerically more frequent with denosumab than with zoledronic acid in the trial (2.0% ... MedPage Today Zoledronic Acid Improves Bone Loss Associated With Adjuvant AI Therapy in ... - Dec 15, 2009 ..."The final results of the study show that upfront zoledronic acid is increasingly more effective than delayed zoledronic acid in preventing bone loss ... DG News Bone Drugs May Beat Back Breast Cancer - Dec 11, 2009 Researchers from the University of Pittsburgh Cancer Institute, led by Brufsky, concluded that zoledronic acid, another bisphosphonate, ... ABC News Options for Bone Loss, but No Magic Pill - Jan 4, 2010 To further simplify the frequency of administration, Reclast (zoledronic acid) was developed as a once-a-year intravenous treatment. ... New York Times NASA ISS On-Orbit Status 3 January 2010 - Jan 3, 2010 The rationale for including both Alendronate and Zoledronic Acid is that two dosing options will maximize crew participation, increase the countermeasure ... Space Ref (press release) Is there a role for ibandronate in the treatment of prostate cancer patients ... - Dec 13, 2009 Zoledronic acid is widely accepted as the treatment of choice for a number of cancers which metastasise to bone and is the only bisphosphonate licensed for ... UroToday SABCS: No Cancer Benefit for Preop Bone Drug - Dec 11, 2009 SAN ANTONIO -- A preoperative dose of bone-building zoledronic acid (Zometa) did not kill breast cancer ... MedPage Today New treatment plan prevents bone loss in breast cancer patients - Dec 27, 2009 Breast cancer patients who are being treated with a certain class of drugs may be able to prevent bone loss side effects by adding zoledronic acid to their ... The Virtual Medical Centre Managing Bone Density and Reducing Breast Cancer: Role of Bisphosphonates - Dec 12, 2009 The Effect of Zoledronic Acid on Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: The ... MedIndia NASA ISS On-Orbit Status 27 December 2009 - Dec 27, 2009 The rationale for including both Alendronate and Zoledronic Acid is that two dosing options will maximize crew participation, increase the countermeasure ... Space Ref (press release) Ibandronate Offers Pain Relief With Renal Safety in Women With Breast Cancer ... - Dec 11, 2009 A baseline creatinine clearance <=60 mL/min was 60% more likely in those pretreated with zoledronic acid compared with ibandronate pretreatment (P =.0061). ... DG News Early surgery advised for hip fracture - Jan 3, 2010 Other osteoporosis treatments such as zoledronic acid, alendronate and risedronatehave also been shown to reduce rates of new fractures. ... 6minutes Denosumab May Be More Effective Than Zometa® for Prevention of Complications ... - Dec 14, 2009 Researchers involved in an international randomized trial have reported that denosumab was more effective than Zometa® (zoledronic acid) for delaying or ... Cancer Consultants Oral Bisphosphonates for Treatment of Osteoporosis May Reduce Risk of ... - Dec 17, 2009 Trial 12 (ABCSG-21) have reported that the addition of adjuvant Zometa® (zoledronic acid) to endocrine therapy for the treatment of hormone-positive, ... Cancer Consultants Treatment Updates - Dec 23, 2009 ...taking denosumab not only had fewer bone complications, but the complications also took longer to develop compared with Zometa (zoledronic acid). ... Curetoday.com (press release) Novartis seeks to expand cancer drug portfolio - Dec 11, 2009 ...the company plans to file regulatory approval applications seeking to expand the use of Tasigna (nilotinib) and Zometa (zoledronic acid) as treatments ... Drug Store News (blog) Novartis confident oncology pipeline will combat off-patent woes - Dec 10, 2009 ...chromosome-positive chronic myeloid leukaemia and Zometa (zoledronic acid) for adjuvant use in certain types of patients with breast cancer. ... Pharma Times Novartis set to sustain its leading global position in oncology with portfolio ... - Dec 12, 2009 Zometa (zoledronic acid) is planned to be submitted for US and EU approval for adjuvant use in certain types of patients with breast cancer based on results ... PR-USA.net (press release) 골다공ì¦? ì¹˜ë£Œì œ, ìœ ë°©ì•” ê°?소 효과 - Dec 10, 2009 ...'í?¬ì‚¬ë§¥ìŠ¤'(Fosamax, alendronate), '조메타'(Zometa, zoledronic acid), '본비바'(Bonviva, ibandronate)와 ê°™ì?€ 비스í?¬ìŠ¤í?¬ë„¤ì?´íŠ¸ 골다공ì¦? ì¹˜ë£Œì œê°€ 2ê°œ 연구 ê²°ê³¼ ... 디지틀보사 노바티스, í•ì•”ì œ 등 ì‹ ì•½ 파ì?´í”„ë?¼ì?¸ ê°•ë ¥ížˆ 구축 - Dec 13, 2009 ...즉, í•„ë?¼ë?¸í”¼ì•„ 염색체 양성 만성 골수성 백혈병ì—? 타시ëƒ?(Tasigna: nilotinib)와 ìœ ë°©ì•” ë³´ì¡° ì¹˜ë£Œì œ 조메타(Zometa: zoledronic acid)를 ê¼½ê³ ìžˆë‹¤. ... 메디포뉴스 Acido zoledronico o risedronato per l'osteoporosi da steroidi - Dec 26, 2009 Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, ... Pillole.org Combination Therapy With Zoledronic Acid/Teriparatide Has Beneficial Effects ... - Oct 20, 2009 PHILADELPHIA -- October 20, 2009 -- Concomitant administration of intravenous zoledronic acid 5 mg once yearly and a 20-mg daily dose of ... DG News Docetaxel-based chemotherapy with zoledronic acid and prednisone in hormone ... - Oct 20, 2009 To evaluate the efficacy of docetaxel/prednisone and zoledronic acid in hormone refractory prostate cancer (HRPC) patients and to analyze prognostic factors ... UroToday NASA ISS On-Orbit Status 8 November 2009 - Nov 8, 2009 The rationale for including both Alendronate and Zoledronic Acid is that two dosing options will maximize crew participation, increase the countermeasure ... Space Ref (press release) NASA ISS On-Orbit Status 9 November 2009 - Nov 9, 2009 The rationale for including both Alendronate and Zoledronic Acid is that two dosing options will maximize crew participation, increase the countermeasure ... Space Ref (press release) NASA ISS On-Orbit Status 2 November 2009 - Nov 3, 2009 The rationale for including both Alendronate and Zoledronic Acid is that two dosing options will maximize crew participation, increase the countermeasure ... Space Ref (press release) Targeting the v β 3 Integrin for Small-Animal PET/CT of Osteolytic Bone Metastases - Oct 29, 2009 These animals were treated with the bisphosphonate zoledronic acid and imaged with 64 Cu-RGD to determine whether this radiopharmaceutical was sensitive ... Journal of Nuclear Medicine (subscription) Vitamin D deficiency despite supplementation in women with breast cancer - Nov 9, 2009 ...part in a multicenter randomized, double-blind, placebo-controlled trial of intravenous zoledronic acid 4 mg administered every 3 months for 1 year. ... American Journal of Hemotology and Oncology Information Lost Between Review and Drug Label - Oct 21, 2009 For instance, they said, in 2001, zoledronic acid (Zometa) was approved for use in patients with hypercalcemia of malignancy based on two clinical trials. ... MedPage Today Solid quarter for Novartis as firm waits for swine flu windfall - Oct 22, 2009 Femara (letrozole), for women with hormone-sensitive breast cancer, climbed 14% to $329 million and Zometa (zoledronic acid) for cancer complications ... Pharma Times Zometa Lawsuit Over Jaw Necrosis Heading to Jury - Oct 20, 2009 Zometa (zoledronic acid) is a treatment that is used to reduce bone complications associated with multiple myeloma and bone metastases from solid tumors. ... AboutLawsuits.com TEDMED 2009 - Day 2 - Oct 29, 2009 Citing a highly successful trial with zoledronic acid (a drug that improves bone growth), he noted that sometimes when you "change the soil" (make the bone ... Medgadget.com IPF 2009 - How to handle side effects of hormone therapy (HT) in prostate ... - Oct 25, 2009 Bisphosphonates such as zoledronic acid are effective in preventing SREs and may improve survival in patients with CRPC by preventing a SRE. ... UroToday Zometa Jaw Necrosis Lawsuit Results in $3.2M Verdict - Oct 23, 2009 Zometa (zoledronic acid) is an intravenous injection that is used to reduce bone complications associated with multiple myeloma and bone metastases from ... AboutLawsuits.com Beyond the Abstract - The critical role of the bone microenvironment in cancer ... - Oct 20, 2009 It can be inhibited by drugs such as the approved bisphosphonate, zoledronic acid. Two newer classes of anti-resorptive drugs developed for use in ... UroToday Buy ALENDRONATE: Amazing prices!Great quality!Bonus pills added! Alendronate. - Oct 31, 2009 Alendronate annual zoledronic acid during the 12 months. If you become pregnant, women. Each tablet once a medication for osteoporosis. In the bathroom. ... Newstalk ZB å°?特定病患 å?ˆä½µå…©ç¨®éª¨è³ªç–?鬆症藥物會比一種好 - Nov 5, 2009 October 27, 2009（費城）ï¼?æ ¹æ“šä¸€é …ç™¼è¡¨æ–¼ç¾Žåœ‹é¢¨æ¿•å…?ç–«å¸æœƒï¼ˆACR）2009å¹´çš„éš¨æ©Ÿåˆ†æ´¾ç ”ç©¶çµ?果，çµ?å?ˆZoledronic acid與Teriparatide，兩種作用機轉ä¸?å?Œï¼Œç”¨ä¾†æ²»ç™‚骨質 ... 臺灣新浪網 æ—¥ ì œë„¤ë¦ ì‹œìž¥ '외ìž?사 진출러시' - Nov 2, 2009 ...rabeprazole), 'ì—?비스타'(Evista, raloxifene), '미카르디스'(Micardis, telmisartan), 'ë ˆí?´ë?¼ìŠ¤íŠ¸'(Reclast, zoledronic acid)ì?˜ 만료가 ì˜ˆì •ë?¼ 있다. ... 디지틀보사 Un estudio de Novartis determina que Aclasta®, en combinación con teriparatida ... - Oct 20, 2009 Effects of once-yearly zoledronic acid 5mg in combination with teriparatide (PTH) on postmenopausal women with osteoporosis. ... Noticias Médicas (Comunicado de prensa) … bone drug, bisphosphonate drug zoledronic acid, gives breast... - Aug 13, 2008 The new study showed that zoledronic acid can have a powerful direct effect on breast cancer without any bone involvement. The results of the clinical trial ... Times Online Zoledronic Acid Protects Bones of Women Getting Breast Cancer … - Aug 19, 2008 TUESDAY, Aug. 19 (HealthDay News) -- Zoledronic acid prevents bone loss in breast cancer patients undergoing endocrine therapy and improves bone mineral ... Washington Post Zoledronic Acid Protects Bones of Women Getting Breast Cancer … - Aug 18, 2008 TUESDAY, Aug. 19 (HealthDay News) -- Zoledronic acid prevents bone loss in breast cancer patients undergoing endocrine therapy and improves bone mineral ... Forbes Annual Infusion of Zoledronic Acid (Reclast) Cuts Risk After Hip... - Sep 18, 2007 By Peggy Peck, Executive Editor, MedPage Today. HONOLULU, Sept. 18 -- An annual infusion of zoledronic acid (Reclast) following surgical repair of a ... MedPage Today Is a single infusion of zoledronic acid superior to risedronate for... - Dec 14, 2005 Reid IR et al. (2005) Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. N Engl J Med 353: 898–908 PubMed ... Nature.com Early Use of Zoledronic Acid Prevents Letrozole-Related Bone Loss - Mar 24, 2006 March 24, 2006 (Nice, France) — Women who receive zoledronic acid (Zometa) at the initiation of breast cancer treatment with letrozole (Femara) have less ... Medscape Is a single infusion of zoledronic acid more effective than oral... - Nov 29, 2005 Reid IR et al. (2005) Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. N Engl J Med 353: 898–908 PubMed ... Nature.com Is yearly intravenous zoledronic acid comparable to weekly oral … - Aug 20, 2007 McClung M et al. (2007) Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate. ... Nature.com Zoledronic acid may shrink breast tumors - Dec 12, 2008 SAN ANTONIO, Dec. 12 (UPI) -- Zoledronic acid may shrink breast tumors when used in addition to chemotherapy, scientists meeting in San Antonio said. ... United Press International 'Healthy Bones' Shot Could Cut Women's Fracture Risk - May 2, 2007 Bisphosphonates, a class of drugs that includes zoledronic acid, ... Previous research had shown that one annual injection of zoledronic acid improved bone ... Washington Post Zoledronic acid ameliorates the effects of endocrine therapy on bone ... - Oct 24, 2008 Twice-yearly zoledronic acid can prevent rapid bone loss associated with the use of goserelin plus tamoxifen or anastrozole for the treatment of ... Nature.com Less is more (bone): yearly osteoporosis drug reduces fractures.(This... - May 5, 2007 Over 3 years, the women who received zoledronic acid intravenously had about ... The Food and Drug Administration approved intravenous zoledronic acid in ... Free with registration - Science News - AccessMyLibrary.com Science File; Drug Proves Effective Against Paget's Disease - Sep 3, 2005 The study found that a single infusion of zoledronic acid, the generic name of ... Zoledronic acid is under review by the Food and Drug Administration as a ... Pay-Per-View - Los Angeles Times - ProQuest Archiver EAU 2006 - ABST [141] Zoledronic acid reduces skeletal morbidity … - Apr 10, 2006 INTRODUCTION & OBJECTIVES: Bone metastasis occurs in approximately 80% of all men during the course of prostate cancer and frequently leads to multiple ... UroToday International Journal A different schedule of zoledronic acid can reduce the risk of the … - Apr 5, 2007 Correspondence: Dr A Corso, Division of Hematology, Policlinico San Matteo, Viale Golgi 19, 27100, Pavia, Italy. E-mail: a.corso@smatteo.pv.it ... Nature.com Two-Year Z-FAST Trial Shows Zoledronic Acid Prevents Bone Loss in … - Dec 18, 2006 By Charlene Laino. SAN ANTONIO, TX -- December 18, 2006 -- Concurrent administration of the third-generation bisphosphonate zoledronic acid (Zometa) appears ... DG News … England Journal of Medicine Finds a Single Infusion of Zoledronic... - Aug 31, 2005 At six months, nearly all patients receiving one dose of zoledronic acid 5 mg ... Specifically, 96 percent of patients treated with zoledronic acid 5 mg ... RedOrbit Zoledronic Acid Prevents Bone Loss after Liver Transplantation - Feb 21, 2006 Background: Clinically important rapid bone loss occurs within 3 to 6 months after liver transplantation and may be associated with osteoporotic fractures. ... Annals of Internal Medicine New drug cocktails show promise against breast cancer - studies - Jun 1, 2008 ...'It's very exciting to find that in addition to preventing bone loss in women undergoing adjuvant endocrine therapy for breast cancer, zoledronic acid can ... Forbes Novartis wins approval letter from FDA for Aclasta to treat Paget's... - Feb 27, 2006 ZURICH (AFX) - Novartis AG last Friday said it has received an approvable letter from the US Food and Drug Administration for zoledronic acid, known under ... Forbes Article: Less is more (bone): yearly osteoporosis drug reduces... - May 5, 2007 Over 3 years, the women who received zoledronic acid intravenously had about ... The Food and Drug Administration approved intravenous zoledronic acid in ... Pay-Per-View - Science News - HighBeam Research Zoledronic Acid and Early Breast Cancer - Jun 1, 2008 June 1, 2008 (updated June 4, 2008) (Chicago, Illinois) — zoledronic acid, a bisphosphonate used for bone metastases and osteoporosis, ... Medscape Bone-building drug needed just once a year. - May 2, 2007 More worrisome, 50 patients on zoledronic acid had to be hospitalized for a heart arrhythmia called atrial fibrillation, compared to 20 in the placebo group ... Free with registration - Philadelphia Inquirer - AccessMyLibrary.com Single Infusion of Zoledronic Acid More Effective in Paget's Disease - Sep 8, 2005 Paget's disease of the bone is characterized by a malfunction in the way bone is built up and broken down at the cellular level, which may result in bone ... RxPG NEWS Early Administration of Zoledronic Acid Benefits Breast Cancer... - Oct 4, 2006 By Jill Stein. ISTANBUL, TURKEY -- October 4, 2006 -- Zoledronic acid is more effective than pamidronate at preventing skeletal events and delaying pain ... DG News Adding Zoledronic Acid to Breast Cancer Therapy Improves Outcomes - Sep 16, 2008 By Jill Stein. STOCKHOLM SEPT 16, 2008 (Reuters Health) - Treatment with the bisphosphonate zoledronic acid along with adjuvant endocrine therapy ... Cancerpage.com Zoledronic acid sustains bone in breast ca patients.(Women's Health)... - Feb 15, 2005 Zoledronic acid sustains bone in breast ca patients.(Women's Health) ... find Family Practice News articles. SAN ANTONIO -- Zoledronic acid prevents the ... Pay-Per-View - Family Practice News - HighBeam Research … Once a Year: When to Discuss Reclast (Zoledronic Acid) with Your... - Aug 27, 2007 Zoledronic acid, however, only needs to be administered once a year, ... (Before the FDA approval for osteoporosis, zoledronic acid was available to treat ... HealthCentral.com Zoledronic acid for Paget's disease ranks well on cost.(Metabolic … - Feb 15, 2006 FT. LAUDERDALE, FLA. -- Zoledronic acid, if approved for the treatment of Paget's disease of bone, could prove a slightly cheaper therapeutic option than ... Free with registration - Family Practice News - AccessMyLibrary.com Sequential Doxorubicin, Zoledronic Acid Have Strong Anti-Breast... - Aug 12, 2008 The use of doxorubicin followed by zoledronic acid reduced tumor size substantially in a mouse model of breast cancer that does not have bone metastases. ... emaxhealth.com … names once-yearly zoledronic acid Aclasta.(Noted) - Pharmaceutical... - Feb 1, 2005 Novartis names once-yearly zoledronic acid Aclasta.(Noted) ... find Pharmaceutical Processing articles. Novartis names once-yearly zoledronic acid Aclasta: ... Pay-Per-View - Pharmaceutical Processing - HighBeam Research ZO-FAST Trial Shows Early Use of Zoledronic Acid Prevents Bone Loss … - Mar 22, 2006 By Paula Moyer. NICE, FRANCE -- March 22, 2006 -- Women with oestrogen receptor-positive breast cancer have less bone loss if they start zoledronic acid ... DG News Reclast (Zoledronic Acid) Once-a-year Osteoporosis Medicine Approved - Aug 19, 2007 Zoledronic acid, sold in the US by Novartis under the brand name Reclast, just received final approval from the FDA for the treatment of osteoporosis. ... HealthCentral.com Zoledronic Acid Added to Neoadjuvant Chemotherapy Provides Important … - Dec 14, 2008 By Jill Stein. SAN ANTONIO, Tex -- December 14, 2008 -- Treatment with the bisphosphonate agent zoledronic acid plus neoadjuvant chemotherapy shrinks breast ... DG News Zoledronic Acid Ups Bone Mineral Density in Men Receiving Hormone … - Oct 12, 2006 By Will Boggs, MD. NEW YORK OCT 12, 2006 (Reuters Health) - Zoledronic acid treatment can increase bone mineral density (BMD) in men with prostate cancer ... Cancerpage.com HORIZON: yearly infusion of zoledronic acid reduces risk of fracture... - Aug 1, 2007 A single, annual intravenous (IV) infusion of zoledronic acid can decrease the risk of vertebral fracture by 70% and the risk of hip fracture by 41% among ... Free with registration - Formulary - AccessMyLibrary.com Bone drugs seen helping fight cancer spread - May 16, 2008 We think that zoledronic acid changes the bone marrow so that cancer cells ... Zometa, known generically as zoledronic acid, is in a class of drugs known as ... Reuters India Article: Zoledronic acid protects bone in breast Ca patients:... - Mar 1, 2005 Zoledronic acid protects bone in breast Ca patients: prophylactic treatment may avert osteoporosis and fractures resulting from aromatase inhibitor therapy. Pay-Per-View - Internal Medicine News - HighBeam Research Article: Zoledronic acid protects bone in premenopausal patients with... - Apr 1, 2005 Zoledronic acid protects bone in premenopausal patients with breast ca.(Gynecology) ... find OB GYN News articles. SAN ANTONIO -- Zoledronic acid prevents ... Pay-Per-View - OB GYN News - HighBeam Research Article: Osteoporosis drug targets breast cancer relapse; In study of... - Jun 1, 2008 Zometa, or zoledronic acid, cut the risk of relapse by 36% in women undergoing hormone ... Article: Zoledronic acid shows protective effect on bone ... ... Pay-Per-View - Milwaukee Journal Sentinel - HighBeam Research Better Outcomes With Zoledronic Acid Than Pamidronate in Multiple … - Dec 13, 2006 By Ed Susman. ORLANDO, FL -- December 13, 2006 -- A subset of patients with multiple myeloma who have elevated bone-specific alkaline phosphate levels ... DG News Zoledronic acid reduces risk for new fractures, improves survival... - Nov 26, 2007 Adverse events were reported at similar rates between the zoledronic acid group and the placebo group. Administering a once-yearly infusion of zoledronic ... Ortho SuperSite Zoledronic acid (Systemic).(Drug overview) - May 1, 2006 Zoledronic acid ( ZOE-le-dron-ik AS-id) is used to treat hypercalcemia (high levels of blood calcium) that may occur in patients with some types of cancer. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Zoledronic Acid Reduces Skeletal Complications of Metastatic Breast … - Jun 16, 2005 NEW YORK JUN 16, 2005 (Reuters Health) - In women who have bone metastases from breast cancer, treatment with the highly potent bisphosphonate zoledronic ... Cancerpage.com Yearly Infusions With Zoledronic Acid Reduce Risk of Fractures in... - May 10, 2007 By Ed Susman. SAN DIEGO, CA -- May 10, 2007 -- A 15-minute intravenous (IV) infusion of zoledronic acid (Zometa) appears sufficient to significantly prevent ... DG News Once-yearly Zoledronic Acid Approved in EU to Treat Osteoporosis in … - Sep 30, 2008 NEW YORK -- September 30, 2008 -- The European Commission has approved once-yearly zoledronic acid (Aclasta) 5 mg for the treatment of osteoporosis in men ... DG News Zoledronic acid (Systemic). - Feb 1, 2006 Zoledronic acid ( ZOE-le-dron-ik AS-id) is used to treat hypercalcemia (high levels of blood calcium) that may occur in patients with some types of cancer. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Zoledronic acid protects bone in breast Ca patients: prophylactic … - Mar 1, 2005 SAN ANTONIO -- Zoledronic acid prevents the profound loss of bone mineral density that often occurs with combined adjuvant endocrine therapy in ... Pay-Per-View - Internal Medicine News - Factiva, from Dow Jones … to Talk to Your Doctor about Zoledronic Acid for Osteoporosis... - Aug 22, 2007 Zoledronic acid, known by its brand name Reclast, is now approved by the FDA for the treatment of osteoporosis. Here is more information that may be useful ... HealthCentral.com Zoledronic Acid IV : User Ratings covering uses, effectiveness, … - Jun 28, 2008 Prescribed for my father to strengthen vertebrae, following surgery to remove secondary tumor in spine. Shortly after treatment began, my father was ... WebMD Single-dose zoledronic acid effective, safe in osteoporosis.( … - Sep 15, 2006 Single-dose zoledronic acid effective, safe in osteoporosis.(Endocrinology)(Clinical report) ... find Internal Medicine News articles. Pay-Per-View - Internal Medicine News - HighBeam Research Breast Cancer; Zoledronic acid prevents bone loss in patients treated... - Jan 1, 2005 2005 JAN 1 - (NewsRx.com & NewsRx.net) -- Zoledronic acid prevents loss of bone mass caused by adjuvant treatment with an aromatase inhibitor or tamoxifen ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Zoledronic Acid Therapy Appears to Protect Solid Tumour Patients … - Jun 7, 2007 By Ed Susman. CHICAGO, IL -- June 7, 2007 -- Cancer patients who are treated with zoledronic acid appear to have a reduced rate of fractures compared with ... DG News Zoledronic Acid (Reclast) Label Expanded to Include Use After Hip … - Jun 6, 2008 By Kristina Fiore, Staff Writer, MedPage Today. EAST HANOVER, NJ, June 6 -- The FDA has expanded the indication for the osteoporosis drug zoledronic acid ... MedPage Today Zoledronic acid could reduce cost of Paget's Tx: given the drug's... - Mar 1, 2006 Zoledronic acid could reduce cost of Paget's Tx: given the drug's higher response rates, overall costs to the managed care plan are expected to be lower. Pay-Per-View - Internal Medicine News - HighBeam Research Nature Clinical Practice Endocrinology & Metabolism - Dec 9, 2008 Twice-yearly zoledronic acid can prevent rapid bone loss associated with the ... By contrast, patients who also received zoledronic acid had stable BMD at ... Nature.com Novartis receives European marketing authorization for Aclasta® - Apr 25, 2005 Novartis Pharma AG announced today that Aclasta® (zoledronic acid 5mg solution ... Zoledronic Acid Produces Higher and More Rapid Therapeutic Response Rates ... i-newswire.com Renal safety of annual zoledronic acid infusions in osteoporotic … - May 28, 2008 The data reported in this manuscript were presented, in part, at the 7th European Congress on Clinical and Economic Aspects of Osteoporosis and ... Nature.com Zoledronic Acid Reduces Mortality After Hip Fracture: Presented at … - Sep 15, 2008 By Louise Gagnon. MONTREAL -- September 15, 2008 -- Therapy with zoledronic acid subsequent to a hip fracture decreases the patient's high mortality risk, ... DG News Zoledronic acid for Paget's disease ranks well on cost.(Metabolic … - Feb 15, 2006 Zoledronic acid for Paget's disease ranks well on cost.(Metabolic Disorders) ... find Family Practice News articles. FT. LAUDERDALE, FLA. Pay-Per-View - Family Practice News - HighBeam Research Article: Yearly zoledronic acid infusion cuts fractures.(Metabolic... - Oct 15, 2007 Yearly zoledronic acid infusion cuts fractures.(Metabolic Disorders) ... find Family Practice News articles. An annual infusion of zoledronic acid reduced ... Pay-Per-View - Family Practice News - HighBeam Research Bone drug may prevent breast cancer spread - May 19, 2008 Lead author Rebecca Aft said the bone-strengthening drug used in the treatment -- zoledronic acid -- decreases bone turnover and reduces bone fractures in ... United Press International Zoledronic Acid Reduces Disability in Women With Osteoporosis: … - May 6, 2008 By Crina Frincu-Mallos, PhD. WASHINGTON, DC -- May 6, 2008 -- In women with osteoporosis, an annual infusion of zoledronic acid reduces disability and leads ... DG News Zoledronic Acid Prevents Bone Loss During Breast Cancer Treatment - Aug 22, 2008 August 22, 2008 — Concomitant zoledronic acid (Zometa, Novartis) that is given during adjuvant endocrine therapy can prevent bone loss in premenopausal ... Medscape Doxorubicin-Zoledronic Acid Sequence Effective Against Breast Cancer ... - Aug 18, 2008 By Will Boggs, MD. NEW YORK AUG 18, 2008 (Reuters Health) - Sequential treatment with doxorubicin followed by zoledronic acid is effective in a mouse model ... Cancerpage.com Zoledronic acid zaps bone loss in breast cancer.(News)(Clinical... - Feb 1, 2008 Zoledronic acid zaps bone loss in breast cancer.(News)(Clinical report) ... find Internal Medicine News articles. SAN ANTONIO -- Zoledronic acid proved ... Pay-Per-View - Internal Medicine News - HighBeam Research Article: Single-dose zoledronic acid rapidly improves bone markers.(Dr... - Jul 15, 2006 Single-dose zoledronic acid rapidly improves bone markers.(Drug overview) ... find Family Practice News articles. TORONTO -- A single intravenous dose of ... Pay-Per-View - Family Practice News - HighBeam Research Zoledronic Acid Better for Bone Remodelling Than Risedronate in … - Jun 15, 2008 By Jill Stein. PARIS -- June 15, 2008 -- In patients with glucocorticoid-induced osteoporosis, a single 5-mg zoledronic-acid infusion is faster and more ... DG News Zoledronic Acid Prevents Bone Loss After Liver Transplantation - Feb 24, 2006 Background: Clinically important rapid bone loss occurs within 3 to 6 months after liver transplantation and may be associated with osteoporotic fractures. ... RedOrbit Zoledronic Acid Protects Against Fractures in Patients With Renal … - May 21, 2008 By Ric Susman. ORLANDO, Fla -- May 21, 2008 -- Patients with renal impairment still can receive protection against fractures by taking courses of zoledronic ... DG News An Argument For The Use Of Zoledronic Acid In Androgen-Sensitive … - Mar 23, 2006 UroToday.com - Bone loss and ensuing skeletal related events such as fractures and pain in men with prostate cancer (CaP) is a result of patient age, ... Medical News Today - Medical News Today (press release) √ An Argument For The Use Of Zoledronic Acid In Androgen-Sensitive … - Mar 20, 2006 BERKELEY, CA (UroToday.com) - Bone loss and ensuing skeletal related events such as fractures and pain in men with prostate cancer (CaP) is a result of ... UroToday International Journal Cancer treatment–induced bone loss and the role of zoledronic acid - May 25, 2008 ...by Jaime Anderson, PharmD; Laura Boehnke Michaud, PharmD, BCOP, FASHP. Individuals undergoing treatment for cancer are known to be at greater risk for bone ... HemOncToday Article: Prostate Ca: annual zoledronic acid protects bone; Prostate ... - Aug 1, 2006 Prostate Ca: annual zoledronic acid protects bone; Prostate cancer patients taking androgen-deprivation therapy had higher BMD after the Zometa treatment. Pay-Per-View - Internal Medicine News - HighBeam Research Zoledronic acid slows bone loss in prostate cancer.(Clinical Rounds)(... - Aug 1, 2006 Zoledronic acid slows bone loss in prostate cancer.(Clinical Rounds)(Disease/Disorder overview) ... find Family Practice News articles. Pay-Per-View - Family Practice News - HighBeam Research Once-yearly zoledronic acid cuts fracture rates: therapy reduced the... - Nov 1, 2006 Once-yearly zoledronic acid cuts fracture rates: therapy reduced the risk by 25% to 75%.(Clinical report) ... find Family Practice News articles. Pay-Per-View - Family Practice News - HighBeam Research Zoledronic acid lowered risk of breast ca relapse.(News) | Article... - Jun 15, 2008 Zoledronic acid lowered risk of breast ca relapse.(News) ... find Family Practice News articles. CHICAGO -- The use of endocrine therapy plus zoledronic ... Pay-Per-View - Family Practice News - HighBeam Research Article: Zoledronic acid cuts risk of breast ca relapses.(Women's... - Sep 1, 2008 Zoledronic acid cuts risk of breast ca relapses.(Women's Health)(Clinical report) ... find Internal Medicine News articles. The addition of zoledronic acid ... Pay-Per-View - Internal Medicine News - HighBeam Research Drug Reduces Fractures, Death After Hip Fracture - Sep 24, 2007 A study of 2127 patients who received the drug zoledronic acid (trade name ... Zoledronic acid is manufactured by Novartis Pharma, which funded the study. ... emaxhealth.com Zoledronic Acid (Zometa) Lessens Skeletal Pain in Advanced Prostate … - Jun 29, 2005 By Jill Stein. PARIS, FRANCE -- June 29, 2005 -- New data suggest that zoledronic acid (Zometa) decreases the skeletal pain related to bone metastases in ... DG News Zoledronic Acid Boosts Survival in Lung Cancer Patients With High N- … - Sep 24, 2007 By Jill Stein. BARCELONA, SPAIN -- September 24, 2007 -- Zoledronic acid treatment appears to improve survival in patients with non-small-cell lung cancer ... DG News Zoledronic Acid Safe in Men With Advanced Prostate or Renal Cancer: … - Mar 28, 2008 By Jill Stein. MILAN, Italy -- March 28, 2008 -- New data demonstrate a favourable safety profile for zoledronic acid in men with bone metastases from ... DG News Continuing Benefit of Zoledronic Acid in Preventing Skeletal … - Nov 22, 2007 We previously reported the efficacy of zoledronic acid 4 mg versus placebo (every 3 weeks for 24 months) for the prevention of skeletal-related events ... UroToday International Journal Upfront Treatment With Zoledronic Acid Prevents Aromatase-Inhibitor- … - Dec 14, 2007 By Ed Susman. SAN ANTONIO, TX -- December 14, 2007 -- Women with hormone-receptor-positive breast cancer who receive zoledronic acid at the same time that ... DG News Zoledronic Acid Reduces Osteosarcoma Lung Metastases in Mice - Jan 2, 2006 NEW YORK JAN 02, 2006 (Reuters Health) - Treatment with zoledronic acid can reduce lung metastases and improve survival in mice inoculated with an ... Cancerpage.com Annual zoledronic acid dose reduces back pain disability.(Endocrinolog... - Nov 1, 2008 Annual zoledronic acid dose reduces back pain disability.(Endocrinology)(Clinical report) ... find Internal Medicine News articles. Pay-Per-View - Internal Medicine News - HighBeam Research Article: Zoledronic acid after hip fracture.(MINDFUL PRACTICE) -... - Feb 15, 2008 Zoledronic acid after hip fracture.(MINDFUL PRACTICE) ... find Internal Medicine News articles. The Problem A 76-year-old woman who is widowed and living ... Pay-Per-View - Internal Medicine News - HighBeam Research EAU 2006 - ABST [139] Zoledronic acid as adjunct to androgen … - Apr 10, 2006 INTRODUCTION & OBJECTIVES: The primary treatment for men with hormone-dependent prostate cancer is androgen deprivation therapy (ADT) with a synthetic ... UroToday International Journal Aclasta(R) (Zoledronic Acid) receives Health Canada approval as first... - Nov 6, 2007 DORVAL, CANADA -- November 6, 2007 -- Aclasta* (zoledronic acid) Injection has been approved by Health Canada as the first and only once-yearly medicine for ... DG News Once-yearly drug infusion shows efficacy for treating, preventing … - Apr 11, 2008 A once-yearly zoledronic acid infusion increases bone mass significantly better than ... A single infusion of zoledronic acid 5 mg is significantly more ... Ortho SuperSite Zoledronic Acid Improves Survival in Patients With Bone Metastases: … - Sep 12, 2007 By Norra MacReady. SEOUL, SOUTH KOREA -- September 12, 2007 -- People with bone metastases from non-small-cell lung cancer (NSCLC) and other solid tumours ... DG News Zoledronic Acid Markedly Effective Against MGUS Bone Loss: Presented ... - Dec 13, 2007 By John Gever. ATLANTA, GA -- December 13, 2007 -- Zoledronic acid increases bone mineral density in the lumbar spine and hip in patients with monoclonal ... DG News Bone drug Zometa helps shink breast tumors-study - Dec 11, 2008 Known generically as zoledronic acid, Zometa is in a class of ... "What these data suggest is perhaps zoledronic acid is doing something more than just ... Reuters Treat Bone Loss in Premenopausal Breast Cancer - Dec 21, 2007 ..."The safety and tolerability of 4 mg zoledronic acid twice a year is ... Zoledronic acid is a third-generation bisphosphonate that appears to reduce or ... Medscape Osteoporosis Drug Seems to Shrink Breast Tumors - Dec 12, 2008 First in the line-up, the osteoporosis drug zoledronic acid (Zometa) appears to ... "This data suggests that zoledronic acid is doing something more than ... Washington Post ASCO 2008 Annual Meeting - Zoledronic Acid in M1 Patients: HRPC … - Aug 22, 2008 Background: There is presently clinical evidence that confirms the value of bisphosphonates in the metastatic bone disease. Zoledronic acid is a ... UroToday International Journal Data Demonstrate Benefits of Once-Yearly Zoledronic Acid for Infusion... - Sep 21, 2006 DORVAL, CANADA -- September 21, 2006 -- Phase 3 data presented for the first time demonstrated that Aclasta* (zoledronic acid 5 mg solution for infusion), ... DG News Zoledronic Acid Offers Remission for Patients With Paget's Disease: … - Sep 14, 2008 By Louise Gagnon. MONTREAL -- September 14, 2008 -- Zoledronic acid demonstrates significant benefit in patients with Paget's disease, according to research ... DG News … Therapy; Docetaxel and zoledronic acid combined with synergistic … - Nov 8, 2005 2005 NOV 8 - (NewsRx.com) -- Docetaxel and zoledronic acid combined with synergistic antitumoral effects on prostate cancer cells in vitro. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Refined bisphosphonate schedule may offer benefit: once-annual dosing... - Sep 1, 2006 This open-label trial randomized 40 men with non-metastatic prostate cancer who were taking GnRH agonists to zoledronic acid, 4 mg IV once annually (20 ... Free with registration - Urology Times - AccessMyLibrary.com |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |